In this episode, Colby and Alin explore the rapidly evolving world of xenotransplantation and what it could mean for patients facing long transplant waitlists. From genetically modified pig organs to early clinical experiences, they discuss the science driving this field forward, the ethical and immunologic challenges that remain, and whether xenotransplantation may serve as a bridge—or an alternative—to traditional human organ donation. Drawing on real-world transplant experience, Colby and ...
All content for Both Sides of the Stethoscope is the property of Colby Salerno, Alin Gragossian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Colby and Alin explore the rapidly evolving world of xenotransplantation and what it could mean for patients facing long transplant waitlists. From genetically modified pig organs to early clinical experiences, they discuss the science driving this field forward, the ethical and immunologic challenges that remain, and whether xenotransplantation may serve as a bridge—or an alternative—to traditional human organ donation. Drawing on real-world transplant experience, Colby and ...
Discussing the NYT Article. Are We Putting Donors at Risk?
Both Sides of the Stethoscope
37 minutes
5 months ago
Discussing the NYT Article. Are We Putting Donors at Risk?
In this episode Alin and Colby discuss the recent New York Times Article titled "A Push for More Organ Transplants is Putting Donors at Risk". What did the article get right? What did it get wrong? Is what's written in the article believable or are some things sensationalized? We break it all down for you from two people with intimate knowledge of this process.
Both Sides of the Stethoscope
In this episode, Colby and Alin explore the rapidly evolving world of xenotransplantation and what it could mean for patients facing long transplant waitlists. From genetically modified pig organs to early clinical experiences, they discuss the science driving this field forward, the ethical and immunologic challenges that remain, and whether xenotransplantation may serve as a bridge—or an alternative—to traditional human organ donation. Drawing on real-world transplant experience, Colby and ...
